|
"huang hsiu chen"的相關文件
顯示項目 21-30 / 45 (共5頁) << < 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目
| 衛生福利部國家中醫藥研究所 |
2015 |
Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts
|
Huang, Cheng;Chen, Yi Jing;Chen, Wei-Jen;Lin, Chih-Li;Wei, Yu Xuan;Huang, Hsiu Chen |
| 衛生福利部國家中醫藥研究所 |
2015 |
Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo
|
Liu, Hui-Kang; Hung, Tzu-Min; Huang, Hsiu-Chen; Lee, I-Jung; Chang, Chia-Chuan; Cheng, Jing-Jy; Lin, Lie-Chwen; Huang, Cheng |
| 國立臺灣大學 |
2015 |
Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo
|
Liu, Hui-Kang; Hung, Tzu-Min; Huang, Hsiu-Chen; Lee, I-Jung; Chang, Chia-Chuan; Cheng, Jing-Jy; Lin, Lie-Chwen; Huang, Cheng; 張嘉銓 |
| 國立成功大學 |
2014-06-27 |
影響彩色濾光片產業轉型策略之研究
|
黃秀貞; Huang, Hsiu-Chen |
| 衛生福利部國家中醫藥研究所 |
2014 |
(−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes
|
Huang, Hsiu-Chen;Tao, Mi-Hua;Hung, Tzu-Min;Chen, Jui-Chieh;Lin, Zi-Jun;Huang, Cheng |
| 衛生福利部國家中醫藥研究所 |
2013 |
Co-treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 cells
|
Huang, Cheng; Lee, Suz-Yi; Lin, Chih-Li; Tu, Tzu-Huei; Chen, Ling-Hsuan; Chen, Yi-Jing; Huang, Hsiu-Chen |
| 衛生福利部國家中醫藥研究所 |
2012-09 |
Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis
|
Huang, Hsiu-Chen; Chen, Chun-Chi; Chang, Wen-Cheng; Tao, Mi-Hua; Huang, Cheng |
| 國立成功大學 |
2012-01-10 |
偏癱中風病人與正常老人在傳統式與V-型傾躺式輪椅之滑移量與坐墊壓力的評估
|
黃秀珍; Huang, Hsiu-Chen |
| 衛生福利部國家中醫藥研究所 |
2012 |
Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin
|
Sun, Shih-Han; Huang, Hsiu-Chen; Huang, Cheng; Lin, Jen-Kun |
| 國立高雄應用科技大學 |
2012 |
臺灣高等技職教育未來發展之探討
|
黃秀珍; Huang, Hsiu-Chen |
顯示項目 21-30 / 45 (共5頁) << < 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目
|